Under newly restructured Centers for Medicare and Medicaid Services guidelines, hospitals are at risk for reduction in reimbursement for patients with heart failure (HF) who are readmitted within 30 days after discharge. Patients with HF who are admitted for an implantable cardioverter defibrillator (ICD) are routinely admitted with a primary diagnosis of HF. To reduce the occurrence of readmission, this article identifies the causes of 30-day readmission and recommends that patient follow-up after ICD placement should include assessment and management of HF symptoms.
Wayne State University College of Nursing, Detroit, Michigan (Drs Oliver-McNeil, McCoy, and George); Department of Heart and Vascular, Beaumont Health Systems, Royal Oak, Michigan (Dr Oliver-McNeil); and Central Michigan University, College of Medicine, Mount Pleasent (Dr Hickman).
Correspondence: Sandra Oliver-McNeil, DNP, ACNP-BC, AACC, Department of Heart and Vascular, Beaumont Health Systems, Royal Oak, Michigan, 5557 Cass Ave, Detroit, MI 48202 (firstname.lastname@example.org).
The authors declare no conflict of interest.
Accepted for publication September 28, 2012.